European Journal of Contraception and Reproductive Health Care最新文献_第2页

Hormonal prolonged-release in oral contraception: how far are we from vaginal pharmacokinetics? 口服避孕药中的激素缓释：我们离阴道药代动力学还有多远？

IF 1.9 4区医学

European Journal of Contraception and Reproductive Health Care Pub Date : 2025-06-01 Epub Date: 2025-04-16 DOI: 10.1080/13625187.2025.2485217

Giovanni Grandi

引用次数: 0

Sociodemographic and reproductive characteristics of pregnant women with unplanned pregnancy residing in the state of São Paulo, Brazil: a cross-sectional study. 居住在巴西圣保罗州的意外怀孕孕妇的社会人口统计学和生殖特征：一项横断面研究。

IF 1.9 4区医学

European Journal of Contraception and Reproductive Health Care Pub Date : 2025-06-01 Epub Date: 2025-03-04 DOI: 10.1080/13625187.2025.2457082

Negli Gallardo-Alvarado, João V Antunes Lopes, Jose Guilherme Cecatti, Miriam Camas-Castillo, Renato T Souza, Luis Bahamondes

{"title":"Sociodemographic and reproductive characteristics of pregnant women with unplanned pregnancy residing in the state of São Paulo, Brazil: a cross-sectional study.","authors":"Negli Gallardo-Alvarado, João V Antunes Lopes, Jose Guilherme Cecatti, Miriam Camas-Castillo, Renato T Souza, Luis Bahamondes","doi":"10.1080/13625187.2025.2457082","DOIUrl":"10.1080/13625187.2025.2457082","url":null,"abstract":"Objective: The aim of our study was to assess the associated factors of planned and unplanned pregnancies (UPs) among pregnant women in São Paulo, Brazil.Methods: We conducted a cross-sectional study from March 2023 to June 2024 and invited pregnant women aged 18 to 49 years. We used the Brazilian-validated version of the London Measure of Unplanned Pregnancy to assess pregnancy intentions. We estimated absolute and relative frequencies of planned and UPs by sociodemographic and reproductive characteristics. Bivariate and multiple regression analysis were performed to evaluate the associated factors for UPs.Results: We included 534 participants; 65.7% reported an UP. Black or Biracial vs White women (74% vs. 57%, p < 0.001), with 0 to 9 years vs. those with >9 of schooling (77% vs. 51%, p < 0.001), and single vs married women (85% vs. 48%, p < 0.001) were associated with UPs. Parous women or those reporting a younger age at their sexual debut were more commonly reported UPs. The associated factors to UPs were being Black or Biracial (Odds ratio [OR] 1.68, 95% Confidence Interval [CI] 1.11;2.57), reporting fewer schooling years (OR 1.61, 95% CI 1.01;2.54), not being married [(OR 2.41, 95% CI 1.53;3.84) for cohabiters and OR 5.23, 95% CI 2.93;9.74) for single] and reporting additional births (OR 1.28, 95% CI 1.07;1.56).Conclusion: Black or Biracial, with fewer years of schooling, not married, and parous women were at a higher risk of UPs. These women tend to face structural barriers to planning the size and timing of their families, requiring actions like increasing tertiary education access and guaranteeing universal modern contraceptive availability to leverage these disadvantages and fulfil their sexual and reproductive rights.","PeriodicalId":50491,"journal":{"name":"European Journal of Contraception and Reproductive Health Care","volume":" ","pages":"137-143"},"PeriodicalIF":1.9,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143544115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Barriers and facilitators for providing pain control during intrauterine device insertion: a multi-center physician survey. 宫内节育器插入过程中疼痛控制的障碍和促进因素：一项多中心医师调查。

IF 1.9 4区医学

European Journal of Contraception and Reproductive Health Care Pub Date : 2025-06-01 Epub Date: 2025-04-22 DOI: 10.1080/13625187.2025.2460015

Abirami Kirubarajan, Seoyeon Han, Anna Gryn, Priyanka Patel, Zuhal Mohmand, Natalie Morson, Mara Sobel

{"title":"Barriers and facilitators for providing pain control during intrauterine device insertion: a multi-center physician survey.","authors":"Abirami Kirubarajan, Seoyeon Han, Anna Gryn, Priyanka Patel, Zuhal Mohmand, Natalie Morson, Mara Sobel","doi":"10.1080/13625187.2025.2460015","DOIUrl":"10.1080/13625187.2025.2460015","url":null,"abstract":"Purpose: To evaluate physicians' barriers and facilitators, as well as knowledge, practices, attitudes, and beliefs, regarding analgesia for IUD insertion.Methodology: A multi-center online survey was conducted from January to July 2023 in Ontario, Canada. Data was analysed using descriptive statistics, chi-square tests, ANOVA, and thematic analysis.Results: Among 85 providers who responded to the survey, there was a lack of consensus regarding provision of analgesia for IUD insertion, as only 52.9% routinely provided pain control. The remaining 40 providers (47.1%) stated that they do not routinely provide pain control for IUD insertion, although 87.5% of participants stated that they would provide pain control if the patient specifically requested analgesia. No differences were found between academic and community staff (p = 0.94) or less experienced providers in provision of pain control (p = 0.24). Reasons for provision of pain control included patient comfort, care, and procedure safety. Conversely, other physicians believed the pain was minimal or short-lived, or faced logistical barriers in providing analgesia.Conclusions: Patients and providers should engage in shared decision-making regarding pain control for IUD insertion.","PeriodicalId":50491,"journal":{"name":"European Journal of Contraception and Reproductive Health Care","volume":" ","pages":"144-148"},"PeriodicalIF":1.9,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144052103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Response to "The evolution of abortion laws: socio-legal insights from the Pre-Roe era and their impact on reproductive health". 对“堕胎法的演变：前罗伊案时代的社会法律见解及其对生殖健康的影响”的回应。

IF 1.9 4区医学

European Journal of Contraception and Reproductive Health Care Pub Date : 2025-06-01 Epub Date: 2025-03-04 DOI: 10.1080/13625187.2025.2466985

Johnny Sakr

引用次数: 0

The evolution of abortion laws: socio-legal insights from the pre-Roe era and their impact on reproductive health. 堕胎法的演变：前罗伊时代的社会法律见解及其对生殖健康的影响。

IF 1.9 4区医学

European Journal of Contraception and Reproductive Health Care Pub Date : 2025-06-01 Epub Date: 2025-03-04 DOI: 10.1080/13625187.2025.2463439

John Patrick C Toledo

引用次数: 0

Real-world use of antispasmodic drugs during IUD insertion - insights from the large observational study EURAS-LCS12. 放置宫内节育器时解痉药物的实际使用情况--大型观察性研究 EURAS-LCS12 的启示。

IF 1.9 4区医学

European Journal of Contraception and Reproductive Health Care Pub Date : 2025-06-01 Epub Date: 2025-04-04 DOI: 10.1080/13625187.2025.2480086

Lisa Eggebrecht, Manuel Rizzo, Moritz Klinghardt, Tanja Böhnke, Clare Barnett, Klaas Heinemann

{"title":"Real-world use of antispasmodic drugs during IUD insertion - insights from the large observational study EURAS-LCS12.","authors":"Lisa Eggebrecht, Manuel Rizzo, Moritz Klinghardt, Tanja Böhnke, Clare Barnett, Klaas Heinemann","doi":"10.1080/13625187.2025.2480086","DOIUrl":"10.1080/13625187.2025.2480086","url":null,"abstract":"Introduction: Antispasmodic drugs are used to facilitate the insertion of intrauterine devices (IUD), and to decrease uterine cramping during the procedure. Evidence supporting these benefits is scarce, and little is known about the prevalence of antispasmodic use before IUD insertion.Methods: EURAS-LCS12 is an ongoing non-interventional cohort study in ten European countries. Information is gathered from health care professionals (HCP) and IUD users via questionnaires at the time of IUD insertion. Patterns of antispasmodics before IUD insertion, by participating country, were assessed using descriptive methods.Results: 96,024 users were included in the study, of which 2.7% (N = 2,565) received antispasmodics before IUD insertion, with notable differences observed between countries. Highest antispasmodic use was observed in France and Germany: in France, almost 50% of HCPs (68/144) gave antispasmodics at least once during the study period. In Germany, 16% of enrolling HCPs used antispasmodics at least once during the study period; two HCPs (0.8%) administered antispasmodics in 69% of all study participants.Conclusion: Clinical practices for prescribing and administering antispasmodics during IUD insertion vary by country and seem to rely on local recommendations, or locally applicable best practices. The heterogeneous use of antispasmodics with uncertain benefits highlights the need for evidence-based recommendations.","PeriodicalId":50491,"journal":{"name":"European Journal of Contraception and Reproductive Health Care","volume":" ","pages":"149-152"},"PeriodicalIF":1.9,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143781719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Patient acceptability of intra-amniotic digoxin versus intracardiac lidocaine for inducing foetal demise prior to second trimester medical abortion: a prospective cohort. 患者对羊膜内地高辛与心内利多卡因在妊娠中期药物流产前诱导胎儿死亡的可接受性：一项前瞻性队列研究

IF 1.9 4区医学

European Journal of Contraception and Reproductive Health Care Pub Date : 2025-04-01 Epub Date: 2025-01-02 DOI: 10.1080/13625187.2024.2444237

Abraham Fessehaye Sium, Sarah Prager, Matthew Reeves

{"title":"Patient acceptability of intra-amniotic digoxin versus intracardiac lidocaine for inducing foetal demise prior to second trimester medical abortion: a prospective cohort.","authors":"Abraham Fessehaye Sium, Sarah Prager, Matthew Reeves","doi":"10.1080/13625187.2024.2444237","DOIUrl":"10.1080/13625187.2024.2444237","url":null,"abstract":"Objective: To compare patient acceptability of inducing foetal demise procedures between intracardiac lidocaine and intra-amniotic digoxin administration prior to second trimester medical abortion.Methods: We enrolled a prospective cohort of women who received either intra-cardiac lidocaine or intra-amniotic digoxin during second trimester medical abortion at later gestation (20-28 weeks) at our centre between April 2023 and March 2024. Data were collected prospectively using a structured questionnaire. For data analysis, Chi-squared test and Fisher's exact test were performed as appropriate. P-value less than 0.05 was used to present results significance.Results: A total of 151 women (101 who had intra-amniotic digoxin injection and 50 women who had foetal intracardiac lidocaine injection) were analysed. The groups had similar mean gestational age (22.42 weeks vs 22.65 weeks, in the digoxin vs lidocaine groups respectively, p-value = 0.50). More women from the digoxin group described the pain associated with foeticide administration as 'as expected' than in the intra-cardiac lidocaine group (48% vs 30%, p-value = 0.005). Similarly, more women in the digoxin group described their overall experience of foeticide administration as 'not bad' compared to those who received intra-cardiac lidocaine (59.4% vs 32%, p-value = 0.006). Likewise, more women in the digoxin group stated they would recommend the same procedure for friends or family members should they face the same problem than in the lidocaine group (43% vs 14%, p-value = 0.001).Conclusions: Our study shows that intra-amniotic digoxin has superior patient acceptability than intracardiac lidocaine by women undergoing safe second trimester medical abortion at later gestion.","PeriodicalId":50491,"journal":{"name":"European Journal of Contraception and Reproductive Health Care","volume":" ","pages":"119-122"},"PeriodicalIF":1.9,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142916129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The pre-Roe legal framework: a dissecting study of the evolution of abortion laws and their socio-legal implications. 罗伊案之前的法律框架：对堕胎法演变及其社会法律影响的剖析研究。

IF 1.9 4区医学

European Journal of Contraception and Reproductive Health Care Pub Date : 2025-04-01 Epub Date: 2025-01-17 DOI: 10.1080/13625187.2024.2448973

Johnny Sakr

{"title":"The pre-Roe legal framework: a dissecting study of the evolution of abortion laws and their socio-legal implications.","authors":"Johnny Sakr","doi":"10.1080/13625187.2024.2448973","DOIUrl":"10.1080/13625187.2024.2448973","url":null,"abstract":"Introduction: The historical evolution of abortion laws in the United States reflects significant shifts in societal attitudes and legal frameworks, particularly concerning reproductive rights and maternal consent. Prior to Roe v. Wade, abortion was largely criminalised, but gradual changes in public opinion and legislation paved the way for liberalised abortion laws.Objective: This study aims to examine the legal and societal developments shaping abortion laws in the United States from the early 19th century to the pre-Roe era, focusing on the interplay between public opinion and legislative milestones.Methods: A historical-legal methodology was employed, analysing primary sources such as court rulings and statutes, alongside secondary literature. The research explores the evolving legal definitions of foetal personhood and maternal autonomy, contextualised within broader societal changes.Results: The findings reveal a transformation in perceptions of abortion, from being viewed as a criminal act to a recognised right influenced by medical, social, and political factors. Legal frameworks increasingly reflected public support for women's autonomy, culminating in the Roe v. Wade decision.Conclusions: This study provides historical context for contemporary abortion debates, highlighting how pre-Roe legal and societal changes continue to inform discussions on women's health, autonomy, and reproductive rights.","PeriodicalId":50491,"journal":{"name":"European Journal of Contraception and Reproductive Health Care","volume":" ","pages":"97-103"},"PeriodicalIF":1.9,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143015619","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A pilot randomised study to compare sub-lingual and vaginal routes of low-dose misoprostol following two sequential doses of mifepristone for second-trimester medical abortion. 一项试点随机研究，比较在连续两次米非司酮治疗中期妊娠药物流产后低剂量米索前列醇的舌下和阴道途径。

IF 1.9 4区医学

European Journal of Contraception and Reproductive Health Care Pub Date : 2025-04-01 Epub Date: 2025-02-13 DOI: 10.1080/13625187.2025.2452178

Pavithra Justa, Rashmi Bagga, Anil E, Subhas Chandra Saha, Jaswinder Kalra, Vanita Jain, Aashima Arora

{"title":"A pilot randomised study to compare sub-lingual and vaginal routes of low-dose misoprostol following two sequential doses of mifepristone for second-trimester medical abortion.","authors":"Pavithra Justa, Rashmi Bagga, Anil E, Subhas Chandra Saha, Jaswinder Kalra, Vanita Jain, Aashima Arora","doi":"10.1080/13625187.2025.2452178","DOIUrl":"10.1080/13625187.2025.2452178","url":null,"abstract":"Primary objective: A randomized study to compare the induction abortion interval (IAI) using two different routes of Low-dose misoprostol administration Sublingual (S/L) and vaginal, after priming with two sequential doses of mifepristone for second-trimester medical abortion.Study design: After randomization in two groups, participants received two doses of mifepristone (200 mg) 24 h apart. On day 3, 200mcg of misoprostol was given by S/L route to group 1 and by vaginal route to group 2, (400mcg among women with gestation ≤16 weeks) and every 6 hours for a maximum of 3 doses.Results: The mean IAI (13.71±8.55 h and 13.22±8.22 h; p=0.768), mean number of misoprostol doses (2.08±1.08 and 2.54±1.12, p=0.05) and mean misoprostol dose (453.9±224.93 and 492.31±208.23 mcg, p=0.409) was similar. The complete abortion rate after 24 h (77.5% vs 87.5%, p=0.23), after 48 h (95% vs 97.5%, p=1.00) and minimal untoward effects seen were all similar in the two groups.Conclusions: Both SL and vaginal routes of misoprostol, after two doses of mifepristone were equally effective. The mean cumulative doses of misoprostol were similar, and a complete abortion rate of > 95% at 48 h was achieved with either route.<math><mo>></mo><mn>95</mn></math>.","PeriodicalId":50491,"journal":{"name":"European Journal of Contraception and Reproductive Health Care","volume":" ","pages":"113-118"},"PeriodicalIF":1.9,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143411355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Evaluating the fidelity of AI-generated information on long-acting reversible contraceptive methods. 评估人工智能生成的长效可逆避孕方法信息的保真度。

IF 1.9 4区医学

European Journal of Contraception and Reproductive Health Care Pub Date : 2025-04-01 Epub Date: 2025-02-06 DOI: 10.1080/13625187.2025.2450011

Grace Riley, Elizabeth Wang, Camille Flynn, Ashley Lopez, Aparna Sridhar

{"title":"Evaluating the fidelity of AI-generated information on long-acting reversible contraceptive methods.","authors":"Grace Riley, Elizabeth Wang, Camille Flynn, Ashley Lopez, Aparna Sridhar","doi":"10.1080/13625187.2025.2450011","DOIUrl":"10.1080/13625187.2025.2450011","url":null,"abstract":"Introduction: Artificial intelligence (AI) has many applications in health care. Popular AI chatbots, such as ChatGPT, have the potential to make complex health topics more accessible to the general public. The study aims to assess the accuracy of current long-acting reversible contraception information provided by ChatGPT.Methods: We presented a set of 8 frequently-asked questions about long-acting reversible contraception (LARC) to ChatGPT, repeated over three distinct days. Each question was repeated with the LARC name changed (e.g., 'hormonal implant' vs 'Nexplanon') to account for variable terminology. Two coders independently assessed the AI-generated answers for accuracy, language inclusivity, and readability. Scores from the three duplicated sets were averaged.Results: A total of 264 responses were generated. 69.3% of responses were accurate. 16.3% of responses contained inaccurate information. The most common inaccuracy was outdated information regarding the duration of use of LARCs. 14.4% of responses included misleading statements based on conflicting evidence, such as claiming intrauterine devices increase one's risk for pelvic inflammatory disease. 45.1% of responses used gender-exclusive language and referred only to women. The average Flesch readability ease score was 42.8 (SD 7.1), correlating to a college reading level.Conclusion: ChatGPT offers important information about LARCs, though a minority of responses are found to be inaccurate or misleading. A significant limitation is AI's reliance on data from before October 2021. While AI tools can be a valuable resource for simple medical queries, users should be cautious of the potential for inaccurate information.Short condensation: ChatGPT generally provides accurate and adequate information about long-acting contraception. However, it occasionally makes false or misleading claims.","PeriodicalId":50491,"journal":{"name":"European Journal of Contraception and Reproductive Health Care","volume":" ","pages":"74-77"},"PeriodicalIF":1.9,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143257247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0